EUVIMEDOdkrijte EUVIMED
Crossref

The Impact of Facility Type and Volume on Outcomes in Head and Neck Mucosal Melanoma

Kelsey M Roman, Sina J Torabi, Benjamin F Bitner, Khodayar Goshtasbi, Yarah M Haidar, Tjoson Tjoa, Edward C Kuan

Otolaryngology–Head and Neck Surgery · 2023-05 · 168 (5) · 1079-1088

DOI: 10.1002/ohn.173 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, published online on 2023-01-25. Written by Kelsey M Roman and 6 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine Medical Center, Orange, California, USA. Major MEDLINE topics: Head and Neck Neoplasms, Melanoma. Cited 12 times so far (Crossref); 49 references.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Objective

To evaluate differences in treatment outcomes for head and neck mucosal melanoma (HNMM) patients seen at academic versus nonacademic centers and high versus low volume facilities. Study Design Retrospective cohort study.

Setting

National Cancer Database.

Methods

Differences in treatment course and overall survival (OS) by facility type and volume were assessed for 2772 HNMM cases reported by the 2004 to 2017 National Cancer Database. A subgroup analysis was performed with a smaller cohort containing staging data. The analysis employed Kaplan‐Meier and Cox proportional hazards models.

Results

A higher proportion of patients treated at academic centers within the HNMM cohort waited longer for surgery after diagnosis ( p < .001), had negative surgical margins ( p < .001), and were readmitted to the hospital within 30 days of surgery ( p = .001); these relationships remained significant when controlling for cancer stage. Kaplan‐Meier analysis demonstrated higher 5‐year OS for patients treated at academic versus nonacademic facilities within the main cohort (32.5% ± 1.3% vs 27.3% ± 1.5%; p = .006) and within the stage‐controlled subgroup (34.8% ± 2.1% vs 27.2% ± 2.6%; p = .003). Treatment at high volume versus low volume facilities was associated with improved 5‐year OS for main cohort patients (33.5% ± 1.7% vs 28.8% ± 1.2%; p = .016) but not for subgroup patients (35.3% ± 2.7% vs 30.1% ± 2.1%; p = .100). Upon multivariate analysis controlling for demographic and oncologic factors, there was no significant difference in OS by facility type (main cohort: odds ratio [OR] = 1.07, 95% confidence interval [CI] = 1.01‐1.21; subgroup: OR = 1.13, 95% CI = 0.97‐1.32).

Conclusion

Neither facility type nor surgical volume predicts overall survival in HNMM.

Subjects

MeSH terms (MEDLINE)

Head and Neck NeoplasmsMelanomaHumansRetrospective StudiesTreatment OutcomeProportional Hazards Models

Author keywords

academic facilitiesfacility typefacility volumehead and neckmucosal melanoma

Authors and institutions

  • Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine Medical Center, Orange, California, USA.

Cite

APA

Roman, K. M., Torabi, S. J., Bitner, B. F., Goshtasbi, K., Haidar, Y. M., Tjoa, T., & Kuan, E. C. (2023). The Impact of Facility Type and Volume on Outcomes in Head and Neck Mucosal Melanoma. Otolaryngology–Head and Neck Surgery, 168(5), 1079-1088. https://doi.org/10.1002/ohn.173

Vancouver

Roman KM, Torabi SJ, Bitner BF, Goshtasbi K, Haidar YM, Tjoa T, et al. The Impact of Facility Type and Volume on Outcomes in Head and Neck Mucosal Melanoma. Otolaryngology–Head and Neck Surgery. 2023;168(5):1079-1088. doi:10.1002/ohn.173

BibTeX
@article{Roman2023,
  author = {Roman, Kelsey M and Torabi, Sina J and Bitner, Benjamin F and Goshtasbi, Khodayar and Haidar, Yarah M and Tjoa, Tjoson and Kuan, Edward C},
  title = {The Impact of Facility Type and Volume on Outcomes in Head and Neck Mucosal Melanoma},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  volume = {168},
  number = {5},
  pages = {1079--1088},
  doi = {10.1002/ohn.173}
}
Start for free →